RxDoctor Payments Data

Hisham Elkadi, MD

Anesthesiology · Melrose, MANPI 1417919168

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $83 of the $118 with a category attached, or 70.0%. Merck accounts for 60.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $55 and has fallen 66.4% since, to $18 in 2025.

$118in general payments, 2019–2025

Across 6 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$72
  • Johnson & Johnson$30
  • Aurinia Pharma U.S., Inc.$17
$374,472in research payments, 2019–2025

Across 33 payments — averaging $11,348 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$374K

What the payments were for

  • Food & beverage$8370%
  • Education$3530%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck4$72
Johnson & Johnson1$30
Aurinia Pharma U.S., Inc.1$17

How this compares

$118 in reported general payments places this provider in the 65th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$43,422
Medicare patients
327
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Melrose

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →